10x Genomics, Inc. (TXG) Form 8-K Material Events
10x Genomics, Inc. (TXG) is a publicly traded company on the Nasdaq, categorized under SIC 3826 (Laboratory Analytical Instruments). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TXG
CIK: 1770787
Exchange: Nasdaq
SIC 3826: Laboratory Analytical Instruments
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerDaniel Coleman
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0001104659-26-114392 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | FORM 4 | 0001610717-26-000422 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | FORM 4 | 0001610717-26-000421 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001968582-26-001003 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | FORM 4 | 0001610717-26-000414 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001950047-26-009250 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | FORM 4 | 0001610717-26-000405 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-08 | — | SCHEDULE 13G Filing | 0000080255-26-000600 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0001610717-26-000396 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001957799-26-000170 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-26 | FORM 4 | 0001610717-26-000393 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001968582-26-000886 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | FORM 4 | 0001610717-26-000392 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | FORM 4 | 0001610717-26-000391 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | FORM 4 | 0001610717-26-000390 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | FORM 4 | 0001610717-26-000389 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001971187-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001786720-26-000003 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001786391-26-000003 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001968582-26-000871 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | FORM 4 | 0001610717-26-000386 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | FORM 4 | 0001610717-26-000359 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001950047-26-008153 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-096964 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001950047-26-008060 | View SEC Doc Filr Page |